1. Most Discussed
  2. Gainers & Losers
NRT 4.0¢

novogen has a excellent half year

  1. munch

    3,567 posts.
    Just released...

    Loss much less than expected... Novogen are on track to break even soon. They are still waiting on their primary patent for the OTC products which should see a massive boost to sales (I'm guessing by multiples, the market in the USA alone is USD500m and growing fast).

    Cash position is excellent and they didn't include the royalty payment paid by DuPont. It certainly looks like they are more than ready to start more clinical trials.

    Chris Naughton also commented this morning they are ready to start doing deals. I'm tipping we'll see a NV-07a deal first. A phenoxodiol deal is also possible as it has the backing of Yale university and other institutions which pick Phenoxodiol as having the great potential.

    All in all an excellent HY report by Novogen. Well done.

DISCLAIMER:
Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.

Top